The group successfully won the bidding of Siwei (Shanghai) biological mRNA nucleic acid new crown vaccine project

Release time:

2021-05-19

The group successfully won the bidding of Siwei (Shanghai) biological mRNA nucleic acid new crown vaccine project

On May 19, the group company successfully won the bidding for the mRNA nucleic acid coronavirus project of Siwei (Shanghai) Biotechnology Co., Ltd in Jinqiao, Shanghai as the EPC general contractor. This is the third new coronavirus vaccine project that Jiangsu Qi 'an has won after the Conxino Coronavirus vaccine project and the Beijing Kexing Zhongwei Coronavirus vaccine project, which were developed by Chen Wei, an academician of the Chinese Academy of Engineering. Sinomicrobiology is an innovative mRNA drug research and development company. With a tight construction period and high professional quality requirements, Sinomicrobiology Group has successfully won the bidding for the mRNA nucleic acid new crown vaccine project through a joint venture with China Pharmaceutical Corporation. "Sinopharmaceutical Engineering" is the top domestic design institute, known as "quality from design"; The Jinhui Branch of the Group, which is responsible for the construction, has been committed to the domestic high-end biomedical engineering for a long time with excellent professional technology, and is good at providing value-added services and creating value for the owners through professional construction technology. Not long ago, Jinhui Branch completed four production lines of Sinovac New Coronavirus Vaccine ahead of schedule and won high praise from all sides. Xu Bin, the person in charge of Jinhui, said that it would fully carry forward the professional and technical advantages of Jiangsu Qi 'an and its experience in the construction of Sinovac vaccine project, work together with the "Chinese Medicine Project" for 95 days to ensure the completion of the construction task with high quality, and help the "Sibiome" contribute to the realization of human victory over COVID-19. (Jinhui Branch)

Group company research Changzhou HeQuan Pharmaceutical Phase III project

Xixiang County, Shaanxi Province government and enterprise investigation team to visit the group company

Recommended news

2026-09-18

Benchmarking against global standards! The Jotun Zhangjiagang project has successfully passed the safety audit conducted by its Norwegian headquarters.

In mid-September, a foreign‑owned owner‑audit expert team from Jotun’s Norwegian headquarters conducted a three‑day, headquarter‑level specialized safety audit at the Jotun Zhangjiagang project site undertaken by the Group.

2026-09-18

The Roche (Shanghai) project of the Group has successfully achieved 2 million safe man-hours.

On September 17, the Roche (Shanghai) Biopharmaceutical Production Base project, undertaken by the Group, successfully reached the milestone of 2 million safe man-hours.

2026-09-18

The Group dispatched personnel to attend the training on building trustworthy quality teams in chemical engineering construction.

On September 16–17, the China Chemical Construction Enterprises Association held a training course on building “Quality‑Trusted Work Teams” in Chengdu, with representatives from the Group in attendance. The training featured a live lecture by Shi Jie, a senior expert of the Association.

2026-09-09

Good News Abounds | The Group Has Secured Multiple Emerging Industry Projects in Succession

In the golden autumn season, bountiful harvests abound, and new‑generation growth sectors showcase their strength. Since August, leveraging its deep-rooted expertise and core competencies in industrial installation, the Group has successively won bids for five key projects in emerging productivity fields, with a total contract value exceeding RMB 250 million, injecting robust momentum into its resilient year‑end performance.

2026-09-03

Two QC achievements of the Group have been awarded at the National Engineering Construction Quality Management Achievement Competition.

Recently, the China Construction Industry Association announced the results of the 2026 Engineering Construction Quality Management Team Achievement Competition. Two QC projects submitted by the Group—“Improving the First-Pass Acceptance Rate for One-Time Forming of Exterior Concrete Moldings” and “Enhancing the First-Pass Welding Acceptance Rate for Dissimilar Steels”—were awarded second and third prizes, respectively.

2026-09-01

The Group convened a special meeting to study and implement the spirit of the branch‑company representatives’ symposium.

On the afternoon of August 31, the Group convened a meeting of heads of regional companies and departmental offices in the fourth-floor conference room at its headquarters to deliberate on the implementation of the spirit of the symposium for branch‑office representatives held by the Group on August 30.